101 related articles for article (PubMed ID: 65226)
1. Experimental studies on the antiarrhythmic action of a lidocaine analog.
Okuma K; Sugiyama S; Wada M; Sugenoya J; Niimi N
Cardiology; 1976; 61(4):289-97. PubMed ID: 65226
[TBL] [Abstract][Full Text] [Related]
2. Effects of SUN-1165, N-(2,6-dimethylphenyl)-8-pyrrolizidine acetamide hydrochloride hemihydrate, a new class I antiarrhythmic drug, on ventricular arrhythmias, intraventricular conduction, and the refractory period in canine myocardial infarction.
Hashimoto H; Satoh N; Nakashima M
J Cardiovasc Pharmacol; 1992 Mar; 19(3):417-24. PubMed ID: 1378123
[TBL] [Abstract][Full Text] [Related]
3. A specific effect of lidocaine and tocainide on ventricular conduction of mid-range extrasystoles.
Man RY; Dresel PE
J Cardiovasc Pharmacol; 1979; 1(3):329-42. PubMed ID: 94400
[TBL] [Abstract][Full Text] [Related]
4. The antiarrhythmic properties of BL-3677A.
Buyniski JP; Gardier RW
J Pharmacol Exp Ther; 1974 Aug; 190(2):289-99. PubMed ID: 4449041
[No Abstract] [Full Text] [Related]
5. [Tetrodotoxin potentiation of the antiarrhythmic action of lidocaine in the late stage of experimental myocardial infarct].
Rozenshtraukh LV; Aniukhovskiĭ EP; Beloshapko GG
Biull Eksp Biol Med; 1981; 91(1):38-40. PubMed ID: 6163491
[TBL] [Abstract][Full Text] [Related]
6. Re-entrant ventricular arrhythmias in the late myocardial infarction period. 4. Mechanism of action of lidocaine.
El-Sherif N; Scherlag BJ; Lazzara R; Hope RR
Circulation; 1977 Sep; 56(3):395-402. PubMed ID: 69503
[TBL] [Abstract][Full Text] [Related]
7. Effect of lidocaine on ventricular conduction in acutely ischemic dog hearts.
Carson DL; Dresel PE
J Cardiovasc Pharmacol; 1983; 5(3):357-63. PubMed ID: 6191132
[TBL] [Abstract][Full Text] [Related]
8. Current understanding of lidocaine as an antiarrhythmic agent: a review.
Anderson JL
Clin Ther; 1984; 6(2):125-41. PubMed ID: 6200230
[TBL] [Abstract][Full Text] [Related]
9. Effects of lidocaine on conduction of extrasystoles in the normal canine heart.
Carson DL; Dresel PE
J Cardiovasc Pharmacol; 1981; 3(5):924-35. PubMed ID: 6168860
[TBL] [Abstract][Full Text] [Related]
10. Lidocaine has a narrow antiarrhythmic dose range against ventricular arrhythmias induced by programmed electrical stimulation in conscious postinfarction dogs.
Krejcy K; Krumpl G; Todt H; Raberger G
Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):213-8. PubMed ID: 1448183
[TBL] [Abstract][Full Text] [Related]
11. Clinical and electrophysiologic studies of R61748 (transcainide): a new class Ic antiarrhythmic drug.
Yang X; Yu T; Kesteloot H
Acta Cardiol; 1992; 47(1):43-56. PubMed ID: 1378674
[TBL] [Abstract][Full Text] [Related]
12. The pharmacology and clinical use of lidocaine as an antiarrhythmic drug--1972.
Harrison DC; Alderman EL
Mod Treat; 1972 Feb; 9(1):139-75. PubMed ID: 4555217
[No Abstract] [Full Text] [Related]
13. Facilitation of reentry by lidocaine in canine myocardial infarction.
Fazekas T; Scherlag BJ; Mabo P; Patterson E; Lazzara R
Acta Physiol Hung; 1994; 82(3):201-13. PubMed ID: 7717083
[TBL] [Abstract][Full Text] [Related]
14. [Studying the mechanism of antiarrhythmic action of a tertiary derivative of lidocaine].
Blinov DS; Kostin IaV; Skachilova SIa
Eksp Klin Farmakol; 2004; 67(3):18-20. PubMed ID: 15341061
[TBL] [Abstract][Full Text] [Related]
15. Effects of lignocaine on intramyocardial conduction in nonischaemic and ischaemic canine myocardium.
Levites R; Haft JJ; Venkatachalapathy D
Cardiovasc Res; 1976 Nov; 10(6):687-90. PubMed ID: 991167
[TBL] [Abstract][Full Text] [Related]
16. Actions of lidocaine on reentrant ventricular rhythms in the subacute myocardial infarction period in dogs.
Yin H; el-Sherif N; Caref EB; Ndrepepa G; Levin R; Isber N; Stergiopolus K; Assadi MA; Gough WB; Restivo M
Am J Physiol; 1997 Jan; 272(1 Pt 2):H299-309. PubMed ID: 9038950
[TBL] [Abstract][Full Text] [Related]
17. Effect of mexiletine on reperfusion-induced ventricular arrhythmias: comparison with lidocaine.
Bonaduce D; Ferrara N; Abete P; Longobardi G; Leosco D; Canonico V; Morgano G; Rengo F
Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):19-29. PubMed ID: 3827408
[TBL] [Abstract][Full Text] [Related]
18. The antiarrhythmic and hemodynamic actions of alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine (MK-251).
Torchiana ML; Stone CA; Wenger HC; Evans R; Lagerquist B; O'Malley T
J Pharmacol Exp Ther; 1975 Aug; 194(2):415-26. PubMed ID: 1151767
[TBL] [Abstract][Full Text] [Related]
19. [The combined effect of 2 first-line anti-arrhythmia drugs on the conduction velocity of myocardial stimulation].
Nesterenko VV; Aniukhovskiĭ EP; Starmer ChF; Beloshapko GG; Ivanovich T; Bugriĭ EM; Mazaev AV; Rozenshtraukh LV
Kardiologiia; 1990 Mar; 30(3):81-7. PubMed ID: 2381129
[TBL] [Abstract][Full Text] [Related]
20. Effects of antiarrhythmic drugs on the repetitive extrasystole threshold and the ventricular fibrillation threshold.
Murakawa Y; Toda I; Nozaki A; Kawakubo K; Sugimoto T
Cardiology; 1989; 76(1):58-66. PubMed ID: 2468414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
